Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.

<h4>Objective</h4>Behavioral symptoms are common after traumatic brain injury (TBI), but their treatments remain unsatisfactory. This systematic review and meta-analysis compared the efficacy and acceptability between blue-wavelength light therapy (BWLT) and long-wavelength/no light ther...

Full description

Bibliographic Details
Main Authors: Karan Srisurapanont, Yanisa Samakarn, Boonyasit Kamklong, Phichayakan Siratrairat, Arina Bumiputra, Montita Jaikwang, Manit Srisurapanont
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0274025
_version_ 1798020328449900544
author Karan Srisurapanont
Yanisa Samakarn
Boonyasit Kamklong
Phichayakan Siratrairat
Arina Bumiputra
Montita Jaikwang
Manit Srisurapanont
author_facet Karan Srisurapanont
Yanisa Samakarn
Boonyasit Kamklong
Phichayakan Siratrairat
Arina Bumiputra
Montita Jaikwang
Manit Srisurapanont
author_sort Karan Srisurapanont
collection DOAJ
description <h4>Objective</h4>Behavioral symptoms are common after traumatic brain injury (TBI), but their treatments remain unsatisfactory. This systematic review and meta-analysis compared the efficacy and acceptability between blue-wavelength light therapy (BWLT) and long-wavelength/no light therapy (LW/NLT) for post-TBI sleepiness, sleep disturbance, depressive symptoms, and fatigue.<h4>Methods</h4>This study included randomized controlled trials comparing the effects of BWLT and LW/NLT on post-TBI sleepiness, sleep disturbance, depression, or fatigue. We searched Pubmed, Embase, CINAHL, and Cochrane Central Register of Controlled of Trials on April 13, 2022. The revised tool for assessing the risk of bias in randomized trials was applied. We performed a frequentist pairwise meta-analysis using a random-effects model.<h4>Results</h4>Of 233 retrieved records, six trials (N = 278) were included in this meta-analysis. TBIs ranged from mild to severe, and the interventions were administered for a median of 35 days. Most trials delivered light therapy via lightboxes. Three trials had a high risk of bias. BWLT was significantly superior to LW/NLT in reducing sleep disturbance (5 trials; SMD = -0.63; 95% CI = -1.21 to -0.05; p = 0.03; I2 = 61%) and depressive symptoms (4 trials; SMD = -1.00; 95% CI = -1.62 to -0.38; p < 0.01; I2 = 56%). There were trends that BWLT was superior to LW/NLT in reducing sleepiness (6 trials; SMD = -0.92; 95% CI = -1.84 to 0.00; p = 0.05; I2 = 88%) and fatigue (4 trials; SMD = -1.44; 95% CI = -2.95 to 0.08; p = 0.06; I2 = 91%). All-cause dropout rates were not significantly different between groups.<h4>Conclusion</h4>Limited and heterogenous evidence suggests that short-term BWLT is well accepted, has a large treatment effect on post-TBI depressive symptoms, and may have a moderate treatment effect on post-TBI sleep disturbance.
first_indexed 2024-04-11T16:55:50Z
format Article
id doaj.art-b433acb7d7e24ba48d5bb3b713722284
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T16:55:50Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b433acb7d7e24ba48d5bb3b7137222842022-12-22T04:13:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011710e027402510.1371/journal.pone.0274025Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.Karan SrisurapanontYanisa SamakarnBoonyasit KamklongPhichayakan SiratrairatArina BumiputraMontita JaikwangManit Srisurapanont<h4>Objective</h4>Behavioral symptoms are common after traumatic brain injury (TBI), but their treatments remain unsatisfactory. This systematic review and meta-analysis compared the efficacy and acceptability between blue-wavelength light therapy (BWLT) and long-wavelength/no light therapy (LW/NLT) for post-TBI sleepiness, sleep disturbance, depressive symptoms, and fatigue.<h4>Methods</h4>This study included randomized controlled trials comparing the effects of BWLT and LW/NLT on post-TBI sleepiness, sleep disturbance, depression, or fatigue. We searched Pubmed, Embase, CINAHL, and Cochrane Central Register of Controlled of Trials on April 13, 2022. The revised tool for assessing the risk of bias in randomized trials was applied. We performed a frequentist pairwise meta-analysis using a random-effects model.<h4>Results</h4>Of 233 retrieved records, six trials (N = 278) were included in this meta-analysis. TBIs ranged from mild to severe, and the interventions were administered for a median of 35 days. Most trials delivered light therapy via lightboxes. Three trials had a high risk of bias. BWLT was significantly superior to LW/NLT in reducing sleep disturbance (5 trials; SMD = -0.63; 95% CI = -1.21 to -0.05; p = 0.03; I2 = 61%) and depressive symptoms (4 trials; SMD = -1.00; 95% CI = -1.62 to -0.38; p < 0.01; I2 = 56%). There were trends that BWLT was superior to LW/NLT in reducing sleepiness (6 trials; SMD = -0.92; 95% CI = -1.84 to 0.00; p = 0.05; I2 = 88%) and fatigue (4 trials; SMD = -1.44; 95% CI = -2.95 to 0.08; p = 0.06; I2 = 91%). All-cause dropout rates were not significantly different between groups.<h4>Conclusion</h4>Limited and heterogenous evidence suggests that short-term BWLT is well accepted, has a large treatment effect on post-TBI depressive symptoms, and may have a moderate treatment effect on post-TBI sleep disturbance.https://doi.org/10.1371/journal.pone.0274025
spellingShingle Karan Srisurapanont
Yanisa Samakarn
Boonyasit Kamklong
Phichayakan Siratrairat
Arina Bumiputra
Montita Jaikwang
Manit Srisurapanont
Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.
PLoS ONE
title Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.
title_full Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.
title_fullStr Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.
title_full_unstemmed Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.
title_short Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials.
title_sort efficacy and acceptability of blue wavelength light therapy for post tbi behavioral symptoms a systematic review and meta analysis of randomized controlled trials
url https://doi.org/10.1371/journal.pone.0274025
work_keys_str_mv AT karansrisurapanont efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT yanisasamakarn efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT boonyasitkamklong efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT phichayakansiratrairat efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT arinabumiputra efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT montitajaikwang efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT manitsrisurapanont efficacyandacceptabilityofbluewavelengthlighttherapyforposttbibehavioralsymptomsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials